Bohai Pharmaceuticals Group, Inc. Receivables Turnover Ratio (BOPH), from the first quarter 2015 to the first quarter 2014 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bohai Pharmaceuticals Group, Inc.  (BOPH)
 

Bohai Pharmaceuticals Group Accounts Receivables Turnover Ratio from the first quarter 2015 to the first quarter 2014

Quarterly Results, Trends, Rankings, Statistics


Bohai Pharmaceuticals Group, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2015 to a ratio of 4.17, this represents a new company high. This is a clear indication for improving liquidity at Bohai Pharmaceuticals Group, Inc.'s clients. Average receivable collection period, for the Bohai Pharmaceuticals Group in Sep 30 2014 quarter, has decreased to 88 days, compared to 91 days, in the Jun 30 2014 quarter.

If we take a look into Healthcare sector 268 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2014 from 1141 to 2913.

What is Receivable Turnover Ratio?
What is Bohai Pharmaceuticals Group, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BOPH Receivables Turnover Ratio (Sep 30 2014)
I. Quarter		 (Jun 30 2014)
IV. Quarter		 (Mar 31 2014)
III. Quarter		 (Dec 31 2013)
II. Quarter		 (Sep 30 2013)
I. Quarter
Y / Y Receivable Change -8.07 % 7.57 % 13.41 % 7.05 % 21.6 %
Y / Y Revenue Change 7.57 % 12.47 % 14.19 % -5.52 % 43.96 %
Receivable Turnover Ratio (TTM) 4.17 4 3.95 3.96 4.09
BOPH's Total Ranking # 2913 # 1141 # 2810 # 1174 # 2467
Accounts Receivable average collection period days 88 91 92 92 89
Seq. Receivable Change -9.5 % -10.43 % 1.32 % 11.93 % 5.9 %
Seq. Revenue Change 19.52 % 15.31 % 2.71 % -24 % 24.96 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 21
Healthcare Sector # 269
Overall Market # 2913

Receivable Turnover Ratio Statistics
High Average Low
4.17 3.82 2.69
(Sep 30 2014)   (Mar 31 2012)





BOPH Company Profile • Back to BOPH Efficiency Comparisons • Compare BOPH Receivables Turnover Ratio to its Competitors

Financial Statements
Bohai Pharmaceuticals Group's Accounts Receivable $ 38 Millions Visit BOPH's Balance sheet
Bohai Pharmaceuticals Group's Sales TTM $ 179 Millions Visit BOPH's Income Statement
Sources of BOPH's Revenues Visit BOPH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BOPH's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BOPH's Growth Rates BOPH's Roa BOPH's Inventory Turnover Ratio BOPH's Dividend Comparisons
BOPH's Profitability Ratios BOPH's Roi BOPH's Asset Turnover Ratio BOPH's Dividend Growth
BOPH's Valuation Ratios BOPH's Roe BOPH's Financial Strength Ratios BOPH's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2014 Receivable at quarter ending Sep 30 2014
Interpace Biosciences Inc   12.87 $ 144.612  Millions$ 11.239  Millions
Aethlon Medical Inc   12.82 $ 1.314  Millions$ 0.102  Millions
Musclepharm Corporation  12.58 $ 182.210  Millions$ 14.485  Millions
Dyax Corp  12.48 $ 71.493  Millions$ 5.730  Millions
Hca Healthcare Inc   12.12 $ 65,737.000  Millions$ 5,423.250  Millions
Strata Skin Sciences Inc  12.05 $ 0.680  Millions$ 0.056  Millions
Alaunos Therapeutics Inc   11.97 $ 1.233  Millions$ 0.103  Millions
Immucell Corporation  11.86 $ 6.951  Millions$ 0.586  Millions
Noho, Inc.  11.83 $ 1.177  Millions$ 0.100  Millions
Merrimack Pharmaceuticals Inc  11.28 $ 76.674  Millions$ 6.796  Millions
Aspira Women s Health inc   11.19 $ 2.548  Millions$ 0.228  Millions
Procyon Corporation  11.18 $ 2.726  Millions$ 0.244  Millions
Rockwell Medical inc   11.16 $ 53.705  Millions$ 4.814  Millions
Surmodics Inc   11.13 $ 57.439  Millions$ 5.162  Millions
Davita Inc   10.93 $ 20,250.401  Millions$ 1,851.960  Millions
Encision Inc   10.93 $ 9.975  Millions$ 0.913  Millions
Amedisys Inc  10.88 $ 1,197.600  Millions$ 110.069  Millions
Neurometrix Inc   10.66 $ 5.505  Millions$ 0.517  Millions
Dendreon Corp  10.61 $ 298.949  Millions$ 28.166  Millions
Genmark Diagnostics Inc   10.60 $ 27.219  Millions$ 2.568  Millions
American Caresource Holdings, Inc.  10.52 $ 23.952  Millions$ 2.277  Millions
First Choice Healthcare Solutions Inc   10.46 $ 18.539  Millions$ 1.773  Millions
Corcept Therapeutics Inc  10.41 $ 21.653  Millions$ 2.080  Millions
National Healthcare Corp  10.39 $ 852.105  Millions$ 81.980  Millions
Asensus Surgical Inc   10.21 $ 1.319  Millions$ 0.129  Millions
China Biologic Products Holdings Inc   10.12 $ 227.857  Millions$ 22.505  Millions
Fonar Corporation  10.11 $ 69.659  Millions$ 6.893  Millions
Novavax inc   10.09 $ 32.684  Millions$ 3.239  Millions
Avid Bioservices Inc   10.00 $ 22.155  Millions$ 2.217  Millions
Astrotech Corp  9.91 $ 10.054  Millions$ 1.015  Millions

Date modified: 2026-08-29T17:35:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.